We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...

Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.

Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners ...

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society ...

Defense and security solutions provider KRATOS DEFENSE AND SECURITY SOLUTIONS INC (NASDAQ: KTOS) saw a sell-off by ARK, with 36,628 shares sold between the ARKQ and ARKX (NYSE: ARKX) ETFs, valued at ...

Veracyte Inc (NASDAQ: VCYT) presented its third quarter 2024 business and financial results on November 6, 2024, showcasing exceptional performance with 29% year-over-year revenue growth.

Among a cohort of 1,135 women ages 40 and younger with stage I through III breast cancer, the incidence of LRR was 5.6%, with ...

Champions Oncology has appointed Rob Brainin as Chief Executive Officer and member of the Board of Directors, effective ...

View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

HACKENSACK, NJ / ACCESS Newswire / July 18, 2025 / Champions Oncology (NASDAQ:CSBR), a leading provider of oncology-focused CRO services specializing in preclinical and clinical specialty testing, tod ...